Clinical and Economic Evaluation of Transdermal Oxybutynin in the Treatment of Overactive Bladder in Spain
**Background:** This study evaluated the clinical outcomes and economic results of transdermal oxybutynin compared to fesoterodine, tolterodine, solifenacin, oxybutynin, trospium chloride, and mirabegron for overactive bladder syndrome in Spain. **Materials and Methods:** A Markov model was built w...
Saved in:
Main Authors: | Carlos Crespo, Pedro Blasco, Marcelo Guigini, Jordi Galván |
---|---|
Format: | Article |
Language: | English |
Published: |
Columbia Data Analytics, LLC
2018-01-01
|
Series: | Journal of Health Economics and Outcomes Research |
Online Access: | https://doi.org/10.36469/9811 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Transdermal delivery of tolterodine tartrate for overactive bladder treatment: In vitro and in vivo evaluation
by: Rajabalaya Rajan, et al.
Published: (2017-09-01) -
An Overview of the Clinical Use of Antimuscarinics in the Treatment of Overactive Bladder
by: Anastasios Athanasopoulos, et al.
Published: (2011-01-01) -
Overactive Bladder: Pathophysiology, Diagnostics, and Therapies
by: John P. F. A. Heesakkers, et al.
Published: (2011-01-01) -
Fahr Syndrome Unknown Complication: Overactive Bladder
by: Devrim Tuglu, et al.
Published: (2014-01-01) -
Comparison Of Outcome And Side Effects Profile Of Treatment Of Overactive Bladder With Different Classes Of Drugs
by: Nazish Sarfraz, et al.
Published: (2023-12-01)